Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
COVID-19 convalescent plasma (1 trial)
iron dextran (INFeD) (1 trial)
red blood cells (1 trial)
Coronavirus Infections (Phase 2)
Transfusion Reaction (Phase 2)
Trials (3 total)
Trial APIs (3 total)